World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
46
Citations
10711
World Ranking
4588
National Ranking
2068

Carla Oseroff publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Carla Oseroff sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 81 publications — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Carla Oseroff D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Carla Oseroff sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 46 D-Index — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Carla Oseroff is affiliated with the La Jolla Institute For Allergy & Immunology in the United States. Their professional work focuses on the field of immunology and allergy research within this institution.

No specific information is available regarding Carla Oseroff's recent papers, frequent co-authors, or publication venues. Additionally, there is no recorded data on book publications, main fields or subfields of study, or main research topics associated with their work.

There is also no documented information about awards won or distinctions received by Carla Oseroff.

The lack of detailed publication and research topic data suggests that further public records or indexed databases may provide additional insights into their specific contributions to their field. However, based on the available information, Carla Oseroff's affiliation places them in a research environment known for contributions to allergy and immunology studies in the United States.

Best Publications

  • The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.

    A. Sette;A. Vitiello;B. Reherman;P. Fowler

  • T cells from patients with Parkinson’s disease recognize α-synuclein peptides

    David Sulzer;Roy N. Alcalay;Francesca Garretti;Lucien Cote

  • Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides

    Jeff Alexander;John Sidney;Scott Southwood;Jörg Ruppert

  • Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides.

    M. E. Ressing;A. Sette;R. M. P. Brandt;J. Ruppert

  • Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire

    David A. Ostrov;Barry J. Grant;Yuri A. Pompeu;John Sidney

  • Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population.

    Jason A. Greenbaum;Maya F. Kotturi;Yohan Kim;Carla Oseroff

  • Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones

    K W Wucherpfennig;A Sette;S Southwood;C Oseroff

  • On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs.

    D O'Sullivan;T Arrhenius;J Sidney;M F Del Guercio

  • Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.

    A Valli;A Sette;L Kappos;C Oseroff

  • Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes.

    Ishioka Gy;Fikes J;Hermanson G;Livingston B

  • Immunomic Analysis of the Repertoire of T-Cell Specificities for Influenza A Virus in Humans

    Erika Assarsson;Huynh-Hoa Bui;John Sidney;Qing Zhang

  • Human memory CTL response specific for influenza A virus is broad and multispecific

    Carmen Gianfrani;Carla Oseroff;John Sidney;Robert W Chesnut

  • Functional consequences of engagement of the T cell receptor by low affinity ligands.

    J Alexander;K Snoke;J Ruppert;J Sidney

  • A Quantitative Analysis of the Variables Affecting the Repertoire of T Cell Specificities Recognized after Vaccinia Virus Infection

    Erika Assarsson;John Sidney;Carla Oseroff;Valerie Pasquetto

  • Measurement of MHC/peptide interactions by gel filtration.

    John Sidney;Scott Southwood;Carla Oseroff;Marie-France del Guercio

  • HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions.

    A. Sette;J. Sidney;C. Oseroff;M.-F. Del Guercio

  • Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection.

    R G van der Most;A Sette;C Oseroff;J Alexander

  • Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes

    Erika Assarsson;Jason A. Greenbaum;Magnus Sundström;Lana Schaffer

  • Identification of Db- and Kb-Restricted Subdominant Cytotoxic T-Cell Responses in Lymphocytic Choriomeningitis Virus-Infected Mice

    R G van der Most;K Murali-Krishna;J L Whitton;C Oseroff

  • Development and validation of a broad scheme for prediction of HLA class II restricted T cell epitopes.

    Sinu Paul;Cecilia S. Lindestam Arlehamn;Thomas J. Scriba;Myles B.C. Dillon

  • Altered Helper T Lymphocyte Function Associated with Chronic Hepatitis B Virus Infection and its Role in Response to Therapeutic Vaccination in Humans

    Brian D. Livingston;Jeff Alexander;Claire Crimi;Carla Oseroff

  • Measurement of MHC/peptide interactions by gel filtration or monoclonal antibody capture.

    John Sidney;Scott Southwood;Carrie Moore;Carla Oseroff

Frequent Co-Authors

Alessandro Sette
Alessandro Sette La Jolla Institute For Allergy & Immunology
Bjoern Peters
Bjoern Peters La Jolla Institute For Allergy & Immunology
John Sidney
John Sidney La Jolla Institute For Allergy & Immunology
Howard M. Grey
Howard M. Grey La Jolla Institute For Allergy & Immunology
Scott Southwood
Scott Southwood Johnson & Johnson
Jason A. Greenbaum
Jason A. Greenbaum La Jolla Institute For Allergy & Immunology
David C. Tscharke
David C. Tscharke Australian National University
David H. Broide
David H. Broide University of California, San Diego
Jack R. Bennink
Jack R. Bennink National Institute of Allergy and Infectious Diseases
Michael J. Buchmeier
Michael J. Buchmeier University of California, Irvine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various related healthcare careers, including nursing and mental health specialties. For those interested in nursing, exploring the easiest LPN programs to get into can be a practical starting point. These programs often provide a quicker pathway to entering the healthcare workforce.

If you're aiming to advance your practice, considering the what is the easiest NP program can help you choose a program that balances accessibility with high-quality education. Nurse Practitioner degrees often lead to more specialized roles, especially in mental health care.

For those interested in psychiatric nursing, identifying the top psychiatric mental health nurse practitioner programs online ensures access to quality clinical experiences, which are vital for career advancement.

Affordability is also a key consideration. Exploring the affordable PMHNP programs can help prospective students find quality education options without excessive financial burden.

Best Scientists Citing Carla Oseroff

Trending Scientists